NCT00092872View on ClinicalTrials.gov

A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

359

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Obesity

Interventions

DRUG

MK0557

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092872 - A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED) | Biotech Hunter | Biotech Hunter